Literature DB >> 12502931

Dissolution of the lymphoid follicle is a feature of the HHV8+ variant of plasma cell Castleman's disease.

Hesham M Amin1, L Jeffrey Medeiros, John T Manning, Dan Jones.   

Abstract

The plasma cell variant of Castleman's disease (PCD) may occur in a variety of clinical settings. One recently delineated type of PCD is caused by human herpesvirus 8 (HHV8) infection. Lymph nodes from 25 patients with PCD, including six HHV8+ and 19 HHV8- cases, were studied. Three patients with HHV8+ PCD were also infected with human immunodeficiency virus-1. Features common to all cases were interfollicular plasmacytosis and variably hyperplastic and regressed follicle germinal centers. Features associated only with HHV8+ PCD included follicle dissolution resulting from blurring of the mantle zone boundary (p = 0.0001), presence of atypical plasma cells and immunoblasts within these areas (p = 0.0006), and more prominent interfollicular vascular proliferation than in HHV8- PCD. HHV8+ cells were predominantly immunoblasts and small lymphocytes that were highly enriched in the mantle zones of altered follicles. These areas showed a predominance of plasmacytoid forms expressing lambda light chain in four of six cases. The extrafollicular fibroblastic network surrounding altered germinal centers demonstrated marked upregulation of low-affinity nerve growth factor receptor in five of five HHV8+ cases but in only two of 10 HHV8- cases. We conclude that HHV8+ PCD is distinctive histologically because of the accumulation of infected lymphocytes in the mantle zone leading to progressive dissolution of the germinal center and altered regulation of the surrounding stroma.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12502931     DOI: 10.1097/00000478-200301000-00010

Source DB:  PubMed          Journal:  Am J Surg Pathol        ISSN: 0147-5185            Impact factor:   6.394


  8 in total

Review 1.  Molecular biology of KSHV in relation to AIDS-associated oncogenesis.

Authors:  Whitney Greene; Kurt Kuhne; Fengchun Ye; Jiguo Chen; Fuchun Zhou; Xiufen Lei; Shou-Jiang Gao
Journal:  Cancer Treat Res       Date:  2007

2.  Castleman's disease of the spleen.

Authors:  Hee-Jeong Lee; Ho-Jong Jeon; Sang-Gon Park; Chi-Young Park
Journal:  World J Gastroenterol       Date:  2015-02-07       Impact factor: 5.742

Review 3.  Castleman's disease in childhood: report of three cases and review of the literature.

Authors:  Piero Farruggia; Antonino Trizzino; Nunzia Scibetta; Giovanni Cecchetto; Patrizia Guerrieri; Emanuele S G D'Amore; Paolo D'Angelo
Journal:  Ital J Pediatr       Date:  2011-10-20       Impact factor: 2.638

4.  Three patients with both Hodgkin's lymphoma and Castleman's disease: Clinicopathologic correlations and lack of association with HHV-8.

Authors:  Saadiya Haque; Robert van Kirk
Journal:  Indian J Med Paediatr Oncol       Date:  2009-04

5.  The clinical spectrum of Castleman's disease.

Authors:  Angela Dispenzieri; James O Armitage; Matt J Loe; Susan M Geyer; Jake Allred; John K Camoriano; David M Menke; Dennis D Weisenburger; Kay Ristow; Ahmet Dogan; Thomas M Habermann
Journal:  Am J Hematol       Date:  2012-07-13       Impact factor: 10.047

Review 6.  Follicular dendritic cell sarcoma.

Authors:  Fabio Facchetti; Matteo Simbeni; Luisa Lorenzi
Journal:  Pathologica       Date:  2021-10

7.  Kaposi sarcoma herpes virus-associated hemophagocytic syndrome complicated by multicentric castleman disease and kaposi sarcoma in a HIV-negative immunocompetent patient: an autopsy case.

Authors:  Bomi Kim; Yoon Kyung Jeon; Chul Woo Kim
Journal:  J Korean Med Sci       Date:  2009-09-24       Impact factor: 2.153

8.  Multicentric Castleman's disease and Kaposi's sarcoma in a cyclosporin treated, HIV-1 negative patient: case report.

Authors:  JM Bollen; AM Polstra; AC Van Der Kuyl; JF Weel; LA Noorduyn; MHJ Van Oers; M Cornelissen
Journal:  BMC Blood Disord       Date:  2003-12-11
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.